We plan to build on our legacy of product innovation, superior customer services, and operational execution this year and in the future as we continue to help patients with musculoskeletal disease.” Our future continues to look bright as we improve the lives of patients, surgeons, employees and shareholders by working to further achieve our vision. Spine sales, and Enabling Technologies sales. “The fourth quarter of 2022 was a record-setting quarter, with record-breaking total sales, U.S. “Globus Medical was founded twenty years ago with a small group of talented engineers who had a vision of improving care for patients with musculoskeletal disease,” President and CEO Dan Scavilla said in a news release. 31, 2022, for a bottom-line gain of 231.4% on sales growth of 9.79%.Īdjusted to exclude one-time items, earnings per share were 59¢, 3¢ ahead of The Street, where analysts were looking for sales of $276.67 million. The Audubon, Pennsylvania-based company reported profits of $50 million, or 49¢ per share, on sales of $274.5 million for the three months ended Dec. Globus Medical (NYSE:GMED) this week posted fourth-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |